Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134862) titled 'Hyperthermic intraperitoneal chemotherapy (HIPEC) combined with SOX regimen and sintilimab in the treatment of advanced gastric cancer with peritoneal metastasis' on Oct. 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: West China Hospital of Sichuan University
Condition:
advanced gastric/gastroesophageal junction adenocarcinoma with peritoneal metastasis
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-30
Target Sample Size: SOX plus sintilimab+HIPEC group:69;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/sho...